BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 1, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 14, 2010
View Archived Issues
New Inhibitor Keeps Hepatitis C from Getting Itself Together
Read More
Fate Strikes Technology Deal to Expand R&D IPSC Tools
Read More
Corrections & Clarifications
Read More
FDA Calls for Bone Fracture Warnings on Bisphosphonates
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More
Alkermes Aims Higher with New Indication for Vivitrol
With its FDA approval this week, Vivitrol becomes the first non-addictive, non-narcotic, once-monthly treatment for opioid dependence, serving a potential market of 1.3 million addicts in the U.S. (BioWorld Today)
Read More
Regeneron Raises $175.1M in Upsized Public Offering
Read More
